EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Regulatory Role of LncRNAs in Modulating Autophagy and Drug Resistance in Non-Small-Cell Lung Cancer: Focus on Targeted Therapeutic Approaches

Shuncai Dai, Yuxin Zhong, Jianfu Lu, Linjiang Song

Biomolecules · 2025

DOI: 10.3390/biom15070968 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Shuncai Dai und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Carcinoma, Non-Small-Cell Lung, Autophagy, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer remains one of the leading causes of death associated with cancer globally, with non-small cell lung cancer (NSCLC) accounting for 80–85% of all lung cancer cases. Despite its high prevalence, the underlying mechanisms of NSCLC have not been completely clarified, and current therapeutic strategies face significant limitations. Recent research has revealed the important role of long non-coding RNAs (lncRNAs) in NSCLC, particularly in regulating processes such as autophagy and drug resistance. LncRNAs are a class of non-coding RNA molecules, typically with transcript lengths exceeding 200 nucleotides, and have been the subject of extensive investigation in recent years. Their involvement in critical cellular processes has opened up new research avenues for precision medicine in NSCLC. This review aims to offer a comprehensive analysis of the mechanisms by which lncRNAs regulate autophagy and drug resistance in NSCLC, explore their potential clinical applications as diagnostic biomarkers and therapeutic targets, and provide both theoretical foundations and practical guidance to advance precision medicine in this area. By deepening our understanding of the role of lncRNAs in NSCLC, this article also highlights the promising potential of lncRNA-based approaches for the diagnosis and treatment of this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingCarcinoma, Non-Small-Cell LungAutophagyDrug Resistance, NeoplasmLung NeoplasmsHumansGene Expression Regulation, NeoplasticBiomarkers, TumorAnimals

Stichwörter der Autor:innen

autophagybiomarkerschemotherapy resistancelong non-coding RNA (lncRNAs)non-small-cell lung cancer (NSCLC)precision medicinetargeted treatment

Substanzen

RNA, Long NoncodingBiomarkers, Tumor

Autor:innen und Institutionen

  • School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • Biological Science Research Center, Southwest University, Chongqing 400715, China.
  • School of Intelligent Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Dai, S., Zhong, Y., Lu, J., & Song, L. (2025). The Regulatory Role of LncRNAs in Modulating Autophagy and Drug Resistance in Non-Small-Cell Lung Cancer: Focus on Targeted Therapeutic Approaches. Biomolecules. https://doi.org/10.3390/biom15070968

Vancouver

Dai S, Zhong Y, Lu J, Song L. The Regulatory Role of LncRNAs in Modulating Autophagy and Drug Resistance in Non-Small-Cell Lung Cancer: Focus on Targeted Therapeutic Approaches. Biomolecules. 2025. doi:10.3390/biom15070968

BibTeX
@article{Dai2025,
  author = {Dai, Shuncai and Zhong, Yuxin and Lu, Jianfu and Song, Linjiang},
  title = {The Regulatory Role of LncRNAs in Modulating Autophagy and Drug Resistance in Non-Small-Cell Lung Cancer: Focus on Targeted Therapeutic Approaches},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15070968}
}
Kostenlos starten →